IndusLaw advised BRLMs on the deal. Concord Biotech issued Equity Shares aggregating up to ?15,505.21 million (USD 186.58 million). Kotak Mahindra Capital Company Limited, Citigroup Global Markets...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here